Stock Events

Stock Events

Proteostasis Therapeutics 

€0.000000
0
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 42P.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Merck
MRK
Mkt Cap319.99B
Merck & Co., Inc. is a global healthcare company that develops medications and vaccines across various areas, including those that Kineta is involved in, making them direct competitors in the pharmaceutical and biotech space.
Pfizer
PFE
Mkt Cap138.61B
Pfizer Inc. operates in the same biopharmaceutical field as Kineta, focusing on the discovery, development, and manufacture of healthcare products including medicines and vaccines.
Bristol-Myers Squibb
BMY
Mkt Cap118.71B
Bristol-Myers Squibb Company is a competitor due to its engagement in the discovery, development, and marketing of prescription pharmaceuticals in areas overlapping with Kineta's interests.
Gilead Sciences
GILD
Mkt Cap162.98B
Gilead Sciences, Inc. competes with Kineta in the biopharmaceutical sector, particularly in the development and marketing of antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza.
AMGEN
AMGN
Mkt Cap201.93B
Amgen Inc. is a biotechnology company that competes with Kineta by focusing on areas such as oncology/hematology, cardiovascular disease, and inflammation.
Abbvie
ABBV
Mkt Cap461.26B
AbbVie Inc. operates in the same pharmaceutical and biotechnology industry as Kineta, with a focus on immunology, oncology, and virology, among others.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.59B
Regeneron Pharmaceuticals, Inc. is a biotechnology company that competes with Kineta in developing and commercializing medicines for the treatment of serious medical conditions.
Novartis
NVS
Mkt Cap305.1B
Novartis AG is a global healthcare company that competes with Kineta in researching, developing, manufacturing, and marketing a wide range of healthcare products.
Johnson & Johnson
JNJ
Mkt Cap633.19B
Johnson & Johnson is a diverse healthcare company that competes with Kineta through its pharmaceutical segment, which develops and markets drugs in various therapeutic areas.
Astrazeneca
AZN
Mkt Cap302.65B
AstraZeneca PLC is a biopharmaceutical company that competes with Kineta in the development and commercialization of prescription medicines, including those for several diseases that Kineta targets.

About

Kineta, Inc., a clinical stage biotechnology company, develops immunotherapies for oncology, neuroscience, and biodefense. It serves private, government, and industry partners. The company has strategic partnerships with Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Kineta, Inc. was formerly known as Lecura, Inc. The company was incorporated in 2007 and is based in Seattle, Washington.
Show more...
CEO
Meenu Chhabra
Employees
11
Country
United States
ISIN
US74373B1098

Listings

MU
DE
42P.MU
STU
DE
42P.STU

0 Comments

Share your thoughts

FAQ

What is Proteostasis Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Proteostasis Therapeutics stocks are traded under the ticker 42P.STU.
How many employees does Proteostasis Therapeutics have?▼
As of July 09, 2026, the company has 11 employees.
In which sector is Proteostasis Therapeutics located?▼
Proteostasis Therapeutics operates in the Technology sector.
When did Proteostasis Therapeutics complete a stock split?▼
Proteostasis Therapeutics has not had any recent stock splits.
Where is Proteostasis Therapeutics headquartered?▼
Proteostasis Therapeutics is headquartered in Boston, United States.